2.3M XNYS Volume
XNYS 19 Mar, 2025 1:33 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.98 per share. | 10 Mar 2025 | 3,471 | 422,668 | - | 1.0 | 3,402 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 3,471 | 0 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.13 per share. | 21 Feb 2025 | 34,353 | 1,282,621 | - | 3.1 | 107,635 | Common stock |
| Sandra Wallach | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.13 per share. | 21 Feb 2025 | 18,142 | 678,000 | - | 3.1 | 56,843 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 3.13 per share. | 21 Feb 2025 | 13,527 | 419,197 | - | 3.1 | 42,383 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.13 per share. | 21 Feb 2025 | 9,066 | 421,489 | - | 3.1 | 28,406 | Common stock |
| Kang Sun | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 21 Nov 2024 | 33,779 | 1,316,974 | - | 2.0 | 66,362 | Common stock |
| Sandra Wallach | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 21 Nov 2024 | 17,158 | 696,142 | - | 2.0 | 33,709 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 21 Nov 2024 | 8,575 | 430,555 | - | 2.0 | 16,846 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 20 Nov 2024 | 18,170 | 454,131 | - | 2.0 | 35,697 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 20 Nov 2024 | 15,000 | 1,040,950 | - | 2.0 | 29,436 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 20 Nov 2024 | 133,536 | 1,039,187 | - | 1.9 | 256,883 | Common stock |
| Kang Sun | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 202,934 | 202,934 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 208,265 | 208,265 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 208,264 | 208,264 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 41,653 | 41,653 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 967,539 | 967,539 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 1,974,502 | 1,974,502 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 1,171,476 | 1,171,476 | - | - | Stock Option (right to buy) | |
| Steven Chu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 173,554 | 173,554 | - | - | Stock Option (right to buy) | |
| Steven Chu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 173,554 | 173,554 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 3,471 | 3,471 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 27,768 | 27,768 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 3,471 | 3,471 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 139,613 | 139,613 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 41,653 | 41,653 | - | - | Stock Option (right to buy) | |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 03 Sep 2024 | 60,000 | 2,333,042 | - | 1.0 | 60,054 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 03 Sep 2024 | 140,000 | 1,195,000 | - | 0.8 | 112,714 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 03 Sep 2024 | 110,000 | 2,073,042 | - | 0.8 | 88,550 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 03 Sep 2024 | 175,000 | 1,335,000 | - | 0.9 | 164,780 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 03 Sep 2024 | 150,000 | 2,183,042 | - | 0.9 | 140,970 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 03 Sep 2024 | 75,000 | 1,510,000 | - | 1.0 | 74,783 | Common stock |
| Kang Sun | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 21 Aug 2024 | 33,333 | 1,350,753 | - | 1.0 | 34,666 | Common stock |
| Sandra Wallach | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 21 Aug 2024 | 17,606 | 713,300 | - | 1.0 | 18,310 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 21 Aug 2024 | 18,644 | 1,528,251 | - | 1.0 | 19,390 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 21 Aug 2024 | 8,800 | 386,168 | - | 1.0 | 9,152 | Common stock |
| Livingston L. Satterthwaite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 283,019 | 291,639 | - | 0 | Common stock | |
| Justin E. Mirro | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2024 | 4,700,000 | 0 | - | - | Warrants (right to buy) | |
| Justin E. Mirro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 925,900 | 2,393,042 | - | - | Common Stock | |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 12 Jun 2024 | 210,000 | 1,857,142 | - | 1.3 | 272,601 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 12 Jun 2024 | 65,000 | 1,585,000 | - | 1.1 | 73,515 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 12 Jun 2024 | 195,000 | 1,467,142 | - | 1.1 | 220,545 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 12 Jun 2024 | 65,000 | 1,650,000 | - | 1.2 | 79,060 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 1.21 per share. | 12 Jun 2024 | 195,000 | 1,662,142 | - | 1.2 | 236,594 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 12 Jun 2024 | 70,000 | 1,715,000 | - | 1.3 | 90,895 | Common stock |
| Donald R. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 125,000 | 142,895 | - | 0 | Common stock | |
| Kathleen Ann Bayless | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 125,000 | 161,253 | - | 0 | Common stock | |
| Steven Chu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 125,000 | 145,395 | - | 0 | Common stock | |
| Justin E. Mirro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 125,000 | 142,895 | - | 0 | Common stock | |
| Mary E. Gustanski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 114,583 | 146,396 | - | 0 | Common stock | |
| Wen Hsieh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 125,000 | 142,895 | - | 0 | Common stock | |
| Kang Sun | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 21 May 2024 | 19,973 | 1,399,697 | - | 1.3 | 26,516 | Common stock |
| Kang Sun | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 1.36 per share. | 21 May 2024 | 15,611 | 1,384,086 | - | 1.4 | 21,169 | Common stock |
| Sandra Wallach | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 21 May 2024 | 10,549 | 739,151 | - | 1.3 | 14,005 | Common stock |
| Sandra Wallach | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.36 per share. | 21 May 2024 | 8,245 | 730,906 | - | 1.4 | 11,180 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 21 May 2024 | 11,171 | 1,555,626 | - | 1.3 | 14,831 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 1.36 per share. | 21 May 2024 | 8,731 | 1,546,895 | - | 1.4 | 11,839 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.36 per share. | 21 May 2024 | 4,121 | 394,968 | - | 1.4 | 5,588 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 21 May 2024 | 5,272 | 399,089 | - | 1.3 | 6,999 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 12 Apr 2024 | 1,007,867 | 1,566,797 | - | 0.0 | 50,393 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2024 | 1,007,867 | 1 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Apr 2024 | 125,983 | 1,007,868 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 02 Apr 2024 | 125,983 | 558,930 | - | 2.4 | 299,613 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 02 Apr 2024 | 125,983 | 684,913 | - | 0.0 | 6,299 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 558,930 | 558,930 | - | 0 | Common stock | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 374,570 | 404,361 | - | 0 | Common stock | |
| Kang Sun | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 1,419,670 | 1,419,670 | - | 0 | Common stock | |
| Sandra Wallach | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 749,700 | 749,700 | - | 0 | Common stock | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 05 Mar 2024 | 40,200 | 40,200 | - | 0.1 | 2,010 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 05 Mar 2024 | 109,800 | 109,800 | - | 0.1 | 5,490 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 2.92 per share. | 05 Mar 2024 | 109,800 | 0 | - | 2.9 | 320,462 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 2.78 per share. | 05 Mar 2024 | 40,200 | 0 | - | 2.8 | 111,579 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 40,200 | 1,133,851 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 109,800 | 1,174,051 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 06 Feb 2024 | 150,000 | 150,000 | - | 0.1 | 7,500 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 150,000 | 1,283,851 | - | - | Stock Option (right to buy) | |
| Bornstein Jonathan | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 06 Feb 2024 | 150,000 | 0 | - | 4.4 | 663,810 | Common stock |
| Bornstein Jonathan | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 5.05 per share. | 02 Jan 2024 | 25,366 | 0 | - | 5.0 | 128,078 | Common stock |
| Bornstein Jonathan | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 150,000 | 1,433,851 | - | - | Stock Option (right to buy) | |
| Bornstein Jonathan | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 02 Jan 2024 | 150,000 | 150,000 | - | 0.1 | 7,500 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 02 Jan 2024 | 124,634 | 25,366 | - | 4.3 | 538,182 | Common stock |
| Mirro E. Justin | Director | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 12 Dec 2023 | 30,000 | 1,870,000 | - | 3.7 | 110,343 | Common stock |
| E. Mirro Justin | Director | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 12 Dec 2023 | 20,000 | 1,900,000 | - | 3.8 | 76,210 | Common stock |
| Mirro Justin E. | Director | Sale of securities on an exchange or to another person at price $ 3.56 per share. | 12 Dec 2023 | 85,000 | 1,785,000 | - | 3.6 | 302,371 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 12 Dec 2023 | 40,000 | 2,297,142 | - | 3.8 | 152,584 | Common stock |
| Mirro E. Justin | Director | Sale of securities on an exchange or to another person at price $ 3.56 per share. | 12 Dec 2023 | 170,000 | 2,067,142 | - | 3.6 | 605,081 | Common stock |
| E. Mirro Justin | Director | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 12 Dec 2023 | 60,000 | 2,237,142 | - | 3.7 | 220,776 | Common stock |
| E. Mirro Justin | Director | Sale of securities on an exchange or to another person at price $ 3.88 per share. | 05 Dec 2023 | 10,000 | 1,920,000 | - | 3.9 | 38,812 | Common stock |
| Bornstein Jonathan | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 47,756 | 1,686,095 | - | - | Stock Option (right to buy) | |
| Mirro E. Justin | Director | Sale of securities on an exchange or to another person at price $ 4.05 per share. | 05 Dec 2023 | 10,000 | 1,930,000 | - | 4.0 | 40,490 | Common stock |
| Mirro Justin E. | Director | Sale of securities on an exchange or to another person at price $ 3.88 per share. | 05 Dec 2023 | 20,000 | 2,337,142 | - | 3.9 | 77,634 | Common stock |
| Bornstein Jonathan | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 3.88 per share. | 05 Dec 2023 | 54,477 | 0 | - | 3.9 | 211,338 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 47,767 | 1,638,328 | - | - | Stock Option (right to buy) | |
| Bornstein Jonathan | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 05 Dec 2023 | 47,756 | 47,756 | - | 0.1 | 2,388 | Common stock |
| Justin Mirro E. | Director | Sale of securities on an exchange or to another person at price $ 4.31 per share. | 05 Dec 2023 | 10,000 | 1,940,000 | - | 4.3 | 43,065 | Common stock |
| Bornstein Jonathan | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 4.28 per share. | 05 Dec 2023 | 47,756 | 0 | - | 4.3 | 204,496 | Common stock |
| Bornstein Jonathan | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 54,477 | 1,583,851 | - | - | Stock Option (right to buy) | |
| Bornstein Jonathan | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 05 Dec 2023 | 47,767 | 0 | - | 4.0 | 192,243 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 05 Dec 2023 | 54,477 | 54,477 | - | 0.1 | 2,724 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 05 Dec 2023 | 47,767 | 47,767 | - | 0.0 | 2,388 | Common stock |
| Mirro E. Justin | Director | Sale of securities on an exchange or to another person at price $ 4.33 per share. | 05 Dec 2023 | 20,000 | 2,377,142 | - | 4.3 | 86,650 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 4.05 per share. | 05 Dec 2023 | 20,000 | 2,357,142 | - | 4.0 | 80,932 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 3.71 per share. | 28 Nov 2023 | 30,000 | 2,467,142 | - | 3.7 | 111,390 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 4.18 per share. | 28 Nov 2023 | 15,000 | 1,950,000 | - | 4.2 | 62,766 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 4.19 per share. | 28 Nov 2023 | 30,000 | 2,397,142 | - | 4.2 | 125,589 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 28 Nov 2023 | 20,000 | 1,965,000 | - | 4.0 | 80,112 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 28 Nov 2023 | 40,000 | 2,427,142 | - | 4.0 | 160,340 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 28 Nov 2023 | 15,000 | 1,985,000 | - | 3.7 | 55,547 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 20 Nov 2023 | 27,631 | 0 | - | 3.8 | 106,106 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2023 | 27,631 | 1,733,851 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 20 Nov 2023 | 27,631 | 27,631 | - | 0.1 | 1,382 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 07 Nov 2023 | 24,809 | 0 | - | 3.2 | 80,421 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2023 | 49,508 | 1,761,482 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2023 | 48,052 | 1,810,990 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2023 | 24,809 | 1,859,042 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 2.82 per share. | 07 Nov 2023 | 49,508 | 0 | - | 2.8 | 139,652 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 07 Nov 2023 | 49,508 | 49,508 | - | 0.0 | 2,475 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 3.05 per share. | 07 Nov 2023 | 48,052 | 0 | - | 3.1 | 146,664 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 07 Nov 2023 | 48,052 | 48,052 | - | 0.1 | 2,403 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 07 Nov 2023 | 24,809 | 24,809 | - | 0.0 | 1,240 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2023 | 70,329 | 1,963,522 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 10 Oct 2023 | 70,329 | 70,329 | - | 0.0 | 3,516 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 4.36 per share. | 10 Oct 2023 | 70,329 | 0 | - | 4.4 | 306,543 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 10 Oct 2023 | 56,702 | 56,702 | - | 0.0 | 2,835 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 4.16 per share. | 10 Oct 2023 | 56,702 | 0 | - | 4.2 | 236,158 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 10 Oct 2023 | 22,969 | 22,969 | - | 0.0 | 1,148 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 3.90 per share. | 10 Oct 2023 | 22,969 | 0 | - | 3.9 | 89,692 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2023 | 56,702 | 1,906,820 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2023 | 22,969 | 1,883,851 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 19 Sep 2023 | 143,516 | 143,516 | - | 0.1 | 7,176 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Sep 2023 | 6,484 | 2,033,851 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Sep 2023 | 143,516 | 2,040,335 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 4.23 per share. | 19 Sep 2023 | 6,484 | 0 | - | 4.2 | 27,396 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 19 Sep 2023 | 6,484 | 6,484 | - | 0.0 | 324 | Common stock |
| Jonathan Bornstein | President of Amprius Lab | Sale of securities on an exchange or to another person at price $ 4.37 per share. | 19 Sep 2023 | 143,516 | 0 | - | 4.4 | 627,165 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.89 per share. | 14 Sep 2023 | 33,630 | 29,791 | - | 3.9 | 130,727 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.66 per share. | 14 Sep 2023 | 46,370 | 63,421 | - | 3.7 | 169,492 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2023 | 80,000 | 435,962 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 09 Sep 2023 | 80,000 | 109,791 | - | 0.1 | 4,000 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 14 Jun 2023 | 50,000 | 2,558,142 | - | 9.5 | 474,915 | Common stock |
| Justin E. Mirro | Director | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 14 Jun 2023 | 61,000 | 2,497,142 | - | 8.9 | 540,131 | Common stock |
| Mary E. Gustanski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 31,813 | 31,813 | - | 0 | Common stock | |
| Donald R. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 17,895 | 17,895 | - | 0 | Common stock | |
| Steven Chu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 17,895 | 20,395 | - | 0 | Common stock | |
| Justin E. Mirro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 17,895 | 17,895 | - | 0 | Common stock | |
| Wen Hsieh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 17,895 | 17,895 | - | 0 | Common stock | |
| C. Ionel Stefan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 30,000 | 515,962 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 14 Dec 2022 | 30,000 | 30,000 | - | 0.1 | 1,500 | Common stock |
| C. Ionel Stefan | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.20 per share. | 14 Dec 2022 | 209 | 29,791 | - | 7.2 | 1,505 | Common stock |
| Justin E. Mirro | Director | Other type of transaction at price $ 0.00 per share. | 14 Sep 2022 | 4,700,000 | 4,700,000 | - | - | Warrants (right to buy) | |
| Justin E. Mirro | Director | 14 Sep 2022 | 9,857,142 | 13,124,642 | - | - | Common Stock | ||
| Justin E. Mirro | Director | Other type of transaction at price $ 0.00 per share. | 14 Sep 2022 | 13,124,642 | 0 | - | - | Common Stock | |
| Justin E. Mirro | Director | Other type of transaction at price $ 0.00 per share. | 14 Sep 2022 | 2,497,142 | 2,497,142 | - | - | Common Stock | |
| Justin E. Mirro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 111,000 | 2,608,142 | - | - | Common Stock | |
| Justin E. Mirro | Director | Other type of transaction at price $ 0.00 per share. | 14 Sep 2022 | 1,000,000 | 1,000,000 | - | - | Common Stock | |
| Justin E. Mirro | Director | Other type of transaction at price $ 0.00 per share. | 14 Sep 2022 | 1,000,000 | 1,000,000 | - | - | Common Stock | |
| Justin E. Mirro | Director | 14 Sep 2022 | 9,857,142 | 0 | - | - | Class B Ordinary Shares | ||
| Justin E. Mirro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 111,000 | 111,000 | - | - | Warrants (right to buy) | |
| Justin E. Mirro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 200,000 | 200,000 | - | - | Warrants (right to buy) | |
| Donald R. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 270,251 | 270,251 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 727,950 | 727,950 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 727,950 | 727,950 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 545,962 | 545,962 | - | - | Stock Option (right to buy) | |
| Kang Sun | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 1,455,901 | 1,455,901 | - | - | Stock Option (right to buy) | |
| Steven Chu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 270,251 | 270,251 | - | - | Stock Option (right to buy) | |
| Sandra Wallach | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 145,590 | 145,590 | - | - | Stock Option (right to buy) | |
| Sandra Wallach | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 582,360 | 582,360 | - | - | Stock Option (right to buy) | |
| Wen Hsieh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 270,251 | 270,251 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 2,183,851 | 2,183,851 | - | - | Stock Option (right to buy) | |
| Jonathan Bornstein | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 545,962 | 545,962 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 72,795 | 72,795 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 545,962 | 545,962 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 218,385 | 218,385 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 72,795 | 72,795 | - | - | Stock Option (right to buy) | |
| C. Ionel Stefan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 181,987 | 181,987 | - | - | Stock Option (right to buy) |